1.
Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet. 2005;366(9493):1303-14.
2.
Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. Cholangiocarcinoma.
A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224(4):463-73;
discussion 73-5.
3.
Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in understanding a deadly old
disease. J Hepatol. 2006;45(6):856-67.
4.
Endo I, House MG, Klimstra DS, Gonen M, D'Angelica M, Dematteo RP, et al. Clinical
significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma.
Ann Surg Oncol. 2008;15(8):2104-12.
5.
McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular
carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol
Biomarkers Prev. 2006;15(6):1198-203.
6.
Berdah SV, Delpero JR, Garcia S, Hardwigsen J, Le Treut YP. A western surgical experience
of peripheral cholangiocarcinoma. Br J Surg. 1996;83(11):1517-21.
7.
Chu KM, Lai EC, Al-Hadeedi S, Arcilla CE, Jr., Lo CM, Liu CL, et al. Intrahepatic
cholangiocarcinoma. World J Surg. 1997;21(3):301-5; discussion 5-6.
8.
Anderson CD, Pinson CW, Berlin J, Chari RS. Diagnosis and treatment of cholangiocarcinoma.
Oncologist. 2004;9(1):43-57.
9.
Yang J, Yan LN. Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol.
2008;14(41):6289-97.
10.
Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for
the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268-89.
11.
Konstantinidis IT, Arkadopoulos N, Ferrone CR. Surgical management of intrahepatic
cholangiocarcinoma in the modern era: advances and challenges. Chin Clin Oncol. 2016;5(1):9.
12.
Shinohara ET, Mitra N, Guo M, Metz JM. Radiation therapy is associated with improved
survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma.
Int J Radiat Oncol Biol Phys. 2008;72(5):1495-501.
13.
Zheng X, Chen B, Wu JX, Jia AY, Rong WQ, Wang LM, et al. Benefit of adjuvant radiotherapy
following narrow-margin hepatectomy in patients with intrahepatic cholangiocarcinoma
that adhere to major vessels. Cancer Manag Res. 2018;10:3973-81.
14.
Jiang W, Zeng ZC, Tang ZY, Fan J, Zhou J, Zeng MS, et al. Benefit of radiotherapy
for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph
node metastases. J Cancer Res Clin Oncol. 2010;136(9):1323-31.
15.
Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary
tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30(16):1934-40.
16.
Hammad AY, Berger NG, Eastwood D, Tsai S, Turaga KK, Christian KK, et al. Is Radiotherapy
Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical
Margins and Lymph Node Status on Survival. Ann Surg Oncol. 2016;23(Suppl 5):912-20.
17.
Edge SB, Byrd DR, Carducci MA, Compton CC, Fritz AG, Greene FL, et al. editors. AJCC
staging manual. 7th edition. New York: Springer-Verlag, 2010.
18.
Song S, Kim K, Chie EK, Kim S, Park HJ, Yi NJ, et al. Locoregional recurrence after
curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant
radiotherapy. Clin Transl Oncol. 2015;17(10):825-9.
19.
Luvira V, Eurboonyanun C, Bhudhisawasdi V, Pugkhem A, Pairojkul C, Luvira V, et al.
Patterns of Recurrence after Resection of Mass-Forming Type Intrahepatic Cholangiocarcinomas.
Asian Pac J Cancer Prev. 2016;17(10):4735-9.
20.
Gil E, Joh JW, Park HC, Yu JI, Jung SH, Kim JM. Predictors and patterns of recurrence
after curative liver resection in intrahepatic cholangiocarcinoma, for application
of postoperative radiotherapy: a retrospective study. World J Surg Oncol. 2015;13:227.
21.
Hyder O, Hatzaras I, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Recurrence
after operative management of intrahepatic cholangiocarcinoma. Surgery. 2013;153(6):811-8.
22.
Doussot A, Gonen M, Wiggers JK, Groot-Koerkamp B, DeMatteo RP, Fuks D, et al. Recurrence
Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma:
Preoperative and Postoperative Prognostic Models. J Am Coll Surg. 2016;223(3):493-505
e2.
23.
Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z, et al. Prognostic nomogram for intrahepatic
cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188-95.
24.
Ribero D, Pinna AD, Guglielmi A, Ponti A, Nuzzo G, Giulini SM, et al. Surgical Approach
for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional
Analysis of 434 Patients. Arch Surg. 2012;147(12):1107-13.
25.
Farges O, Fuks D, Boleslawski E, Le Treut YP, Castaing D, Laurent A, et al. Influence
of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a
multicenter study by the AFC-IHCC-2009 study group. Ann Surg. 2011;254(5):824-29;
discussion 30.
26.
de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Intrahepatic
cholangiocarcinoma: an international multi-institutional analysis of prognostic factors
and lymph node assessment. J Clin Oncol. 2011;29(23):3140-5.
27.
Jiang W, Zeng ZC, Tang ZY, Fan J, Sun HC, Zhou J, et al. A prognostic scoring system
based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score. Ann
Oncol. 2011;22(7):1644-52.
28.
Zhang GW, Lin JH, Qian JP, Zhou J. Identification of risk and prognostic factors for
patients with clonorchiasis-associated intrahepatic cholangiocarcinoma. Ann Surg Oncol.
2014;21(11):3628-37.
29.
Zhou HB, Wang H, Li YQ, Li SX, Wang H, Zhou DX, et al. Hepatitis B virus infection:
a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.
World J Gastroenterol. 2011;17(10):1292-303.